Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBITDA: 2010-2025

Historic EBITDA for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $29.0 million.

  • Exponent's EBITDA rose 12.35% to $29.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $117.9 million, marking a year-over-year increase of 6.51%. This contributed to the annual value of $119.6 million for FY2025, which is 7.40% up from last year.
  • Exponent's EBITDA amounted to $29.0 million in Q4 2025, which was up 69.05% from $17.2 million recorded in Q3 2025.
  • Exponent's 5-year EBITDA high stood at $45.3 million for Q3 2022, and its period low was $17.2 million during Q3 2025.
  • Moreover, its 3-year median value for EBITDA was $29.1 million (2023), whereas its average is $29.2 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 222.06% in 2021, then crashed by 51.94% in 2025.
  • Exponent's EBITDA (Quarterly) stood at $28.7 million in 2021, then decreased by 23.10% to $22.0 million in 2022, then declined by 16.52% to $18.4 million in 2023, then dropped by 23.83% to $25.8 million in 2024, then rose by 12.35% to $29.0 million in 2025.
  • Its EBITDA was $29.0 million in Q4 2025, compared to $17.2 million in Q3 2025 and $44.4 million in Q2 2025.